Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-07-01 Transaction in Own Shar…
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares by Indivior PLC for cancellation on June 28, 2024. It provides specific metrics like the number of shares purchased, highest/lowest/VWAP prices, and the resulting total shares outstanding. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). The presence of the RNS Number and the closing statement referencing RNS and the FCA confirms it is a regulatory disclosure, but the content is specific enough to use the more precise code.
2024-07-01 English
HOLDING(S) IN COMPANY
Regulatory Filings
2024-06-28 English
HOLDING(S) IN COMPANY
Regulatory Filings
2024-06-28 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document explicitly starts with 'RNS Number : 3706U' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification. The filing is clearly a regulatory disclosure related to share ownership thresholds being crossed or reached by Societe Generale. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-06-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as an 'RNS Number' filing from 'Indivior PLC' dated '28 June 2024'. The content is a 'TR-1: Standard form for notification of major holdings', detailing changes in voting rights held by Societe Generale, crossing a threshold on '26-Jan-2024'. This type of mandatory disclosure regarding significant changes in share ownership is specifically covered by the 'Major Shareholding Notification' definition. Although it is an RNS filing, the specific nature of the content points directly to MRQ rather than the general RNS fallback.
2024-06-28 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.